Clinical effect of genetic alterations such as germline DDX41 mutations in MDS/minimal-blast count AML patients taken care of with azacitidine-dependent regimens Marie Sébert The Institute for Wellbeing Metrics and Evaluation's World wide Burden of Disorder (GBD) analyze also provides estimates via modeling techniques that incorporate data from a lot of https://directivepublications.org/journal-of-leukemia-research/